APA (7th ed.) Citation

Jin, L., Liu, W., Tian, M., Jiang, X., Wang, H., Zhou, P., . . . Shi, Y. (2017). CCL24 contributes to HCC malignancy via RhoB- VEGFA-VEGFR2 angiogenesis pathway and indicates poor prognosis. Oncotarget, 8(3), 5135-5148. https://doi.org/10.18632/oncotarget.14095

Chicago Style (17th ed.) Citation

Jin, Lei, et al. "CCL24 Contributes to HCC Malignancy via RhoB- VEGFA-VEGFR2 Angiogenesis Pathway and Indicates Poor Prognosis." Oncotarget 8, no. 3 (2017): 5135-5148. https://doi.org/10.18632/oncotarget.14095.

MLA (9th ed.) Citation

Jin, Lei, et al. "CCL24 Contributes to HCC Malignancy via RhoB- VEGFA-VEGFR2 Angiogenesis Pathway and Indicates Poor Prognosis." Oncotarget, vol. 8, no. 3, 2017, pp. 5135-5148, https://doi.org/10.18632/oncotarget.14095.